Connect Biopharma Holdings Limited (CNTB) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Connect Biopharma Holdings Limited (CNTB) closed at USD 0.91 on 2026-10-15, a change of -42.8 % over the past year, with a market capitalization of USD 57.07M.

Connect Biopharma Holdings Limited recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Connect Biopharma Holdings Limited key figures

Previous close

USD 0.91 (2026-10-15)

1-year change

-42.8 %

Market cap

USD 57.07M

Enterprise value

USD 26.18M

P/E ratio (trailing)

-0.76

P/E ratio (forward)

-1.17

EPS (trailing)

-1.19

EPS (forward)

-0.77

PEG ratio

n/a

Price to book

2.12

Revenue growth

5,666.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.36

Employees

64

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Connect Biopharma Holdings Limited and compare it with other stocks.